ClariTrial | Search Clinical Trials

Explore/eye disease ophthalmology retina

Status

Phase

Pre-filtered to show active, later-stage trials with the strongest clinical signal.

157 results for “eye disease ophthalmology retina” · Recruiting

Page 1 of 11

Recruiting

Treatment of Neovascular AMD: Artificial Intelligence in Real-world Setting

Phase 4Exudative Macular Degeneration

anti-VEGF agentanti-VEGF agent

Medical University of Vienna290 participants1 site · AustriaCompletes Dec 2025

Compare CT.gov Full analysis →

Recruiting

MMP-9 Inhibition for Recalcitrant Wet AMD

Phase 2Exudative Macular DegenerationWet Age-related Macular Degeneration

Doxycycline HyclatePlacebo

University of Iowa50 participants1 site · United StatesCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

Phase 3Age-related Macular Degeneration (AMD)Geographic Atrophy (GA)

PozelimabCemdisiranPlacebo

Regeneron Pharmaceuticals975 participants231 sites · United States, Australia, AustriaCompletes Jul 2028

Compare CT.gov Full analysis →

Recruiting

Phenotypic and Etiological Characterization of Susac Syndrome

N/ASusac Syndrome

Assistance Publique - Hôpitaux de Paris180 participants1 site · FranceCompletes Nov 2044

Compare CT.gov Full analysis →

Recruiting

Eye Diseases "Treated" With Interoperable Medical Informatics

N/AIntravitreal Injections

University Hospital Muenster2,000 participants6 sites · GermanyCompletes Feb 2028

Compare CT.gov Full analysis →

Recruiting

Azathioprine in MOGAD

Phase 3Central Nervous System InflammationMOG-IgG Associated Disease

AzathioprinePlacebo

Hospices Civils de Lyon126 participants17 sites · FranceCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

Safety and Clinical Applicability of Transcorneal Electrical Stimulation (TES) in Geographic Atrophy

N/AGeographic Atrophy Secondary to Age-related Macular Degeneration

Transcorneal electrical stimulation (TES) with the OkuStim 2 SystemTranscorneal electrical stimulation (TES) with the OkuStim 2 System

Okuvision GmbH70 participants5 sites · GermanyCompletes Jun 2028

Compare CT.gov Full analysis →

Recruiting

This Clinical Trial Compares Two Phacoemulsification Systems Used in a Bilateral Cataract Surgery Subjects in Order to Study CDE and Ultrasound Time During Cataract Removal

N/ANuclear Sclerosis of the LensPhacoemulsification Cataract SurgeryCataract Bilateral

Cataract extraction with phacoemulsification comparing two systemsCataract extraction with phacoemulsification comparing two systems

Nicole Fram M.D.30 participants1 site · United StatesCompletes Feb 2027

Compare CT.gov Full analysis →

Recruiting

Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)

Phase 3Optic NeuritisMyelitisMyelitis, Transverse

High-dose corticosteroids (HDCS)High-dose corticosteroids (HDCS) and PLEX

Mayo Clinic382 participants35 sites · United StatesCompletes Apr 2029

Compare CT.gov Full analysis →

Recruiting

Spring Loaded Syringe for Active Silicon Oil Extraction

N/ARetinal Detachment

Vitrectomy machineSpring loaded syringe

Sohag University200 participants1 site · EgyptCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

Electrical Stimulation for Vision Neuroenhancement in Glaucoma

N/AGlaucomaGlaucoma Open-Angle

Eyetronic rtACSSham rtACS

Stanford University30 participants1 site · United StatesCompletes Jun 2027

Compare CT.gov Full analysis →

Recruiting

Ursodeoxycholic Acid (UDCA) as a Neuroprotective Adjuvant Treatment to Rhegmatogenous Retinal Detachment Surgery

Phase 3Retinal Detachment

UrsolvanPlacebo

Hopital Foch120 participants2 sites · FranceCompletes May 2027

Compare CT.gov Full analysis →

Recruiting

IRIS Registry: Intelligent Research in Sight Registry

N/AEye Diseases

Ophthalmology

American Academy of Ophthalmology20,000,000 participants1 site · United StatesCompletes Jan 2100

Compare CT.gov Full analysis →

Recruiting

Impact of Home Intraocular Pressure Telemonitoring on Intraocular Pressure Control and Glaucoma Progression

N/AGlaucomaIntraocular PressurePrimary Open Angle Glaucoma

Home IOP telemonitoring with smart phone-based interventionStandard care and smart phone-based intervention

The University of Hong Kong142 participants1 site · Hong KongCompletes Jun 2028

Compare CT.gov Full analysis →

Recruiting

Patient Preferences on Same-day Bilateral Intravitreal Dexamethasone Injections

N/AInformed ConsentPreference, Patient

Ozurdex (dexamethasone)

Copenhagen University Hospital, Rigshospitalet200 participants1 site · DenmarkCompletes Dec 2025

Compare CT.gov Full analysis →

1–15 of 157

Explore/eye disease ophthalmology retina

Status

Phase

Pre-filtered to show active, later-stage trials with the strongest clinical signal.

157 results for “eye disease ophthalmology retina” · Recruiting

Page 1 of 11

Recruiting

Treatment of Neovascular AMD: Artificial Intelligence in Real-world Setting

Phase 4Exudative Macular Degeneration

anti-VEGF agentanti-VEGF agent

Medical University of Vienna290 participants1 site · AustriaCompletes Dec 2025

Compare CT.gov Full analysis →

Recruiting

MMP-9 Inhibition for Recalcitrant Wet AMD

Phase 2Exudative Macular DegenerationWet Age-related Macular Degeneration

Doxycycline HyclatePlacebo

University of Iowa50 participants1 site · United StatesCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

Phase 3Age-related Macular Degeneration (AMD)Geographic Atrophy (GA)

PozelimabCemdisiranPlacebo

Regeneron Pharmaceuticals975 participants231 sites · United States, Australia, AustriaCompletes Jul 2028

Compare CT.gov Full analysis →

Recruiting

Phenotypic and Etiological Characterization of Susac Syndrome

N/ASusac Syndrome

Assistance Publique - Hôpitaux de Paris180 participants1 site · FranceCompletes Nov 2044

Compare CT.gov Full analysis →

Recruiting

Eye Diseases "Treated" With Interoperable Medical Informatics

N/AIntravitreal Injections

University Hospital Muenster2,000 participants6 sites · GermanyCompletes Feb 2028

Compare CT.gov Full analysis →

Recruiting

Azathioprine in MOGAD

Phase 3Central Nervous System InflammationMOG-IgG Associated Disease

AzathioprinePlacebo

Hospices Civils de Lyon126 participants17 sites · FranceCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

Safety and Clinical Applicability of Transcorneal Electrical Stimulation (TES) in Geographic Atrophy

N/AGeographic Atrophy Secondary to Age-related Macular Degeneration

Transcorneal electrical stimulation (TES) with the OkuStim 2 SystemTranscorneal electrical stimulation (TES) with the OkuStim 2 System

Okuvision GmbH70 participants5 sites · GermanyCompletes Jun 2028

Compare CT.gov Full analysis →

Recruiting

This Clinical Trial Compares Two Phacoemulsification Systems Used in a Bilateral Cataract Surgery Subjects in Order to Study CDE and Ultrasound Time During Cataract Removal

N/ANuclear Sclerosis of the LensPhacoemulsification Cataract SurgeryCataract Bilateral

Cataract extraction with phacoemulsification comparing two systemsCataract extraction with phacoemulsification comparing two systems

Nicole Fram M.D.30 participants1 site · United StatesCompletes Feb 2027

Compare CT.gov Full analysis →

Recruiting

Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)

Phase 3Optic NeuritisMyelitisMyelitis, Transverse

High-dose corticosteroids (HDCS)High-dose corticosteroids (HDCS) and PLEX

Mayo Clinic382 participants35 sites · United StatesCompletes Apr 2029

Compare CT.gov Full analysis →

Recruiting

Spring Loaded Syringe for Active Silicon Oil Extraction

N/ARetinal Detachment

Vitrectomy machineSpring loaded syringe

Sohag University200 participants1 site · EgyptCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

Electrical Stimulation for Vision Neuroenhancement in Glaucoma

N/AGlaucomaGlaucoma Open-Angle

Eyetronic rtACSSham rtACS

Stanford University30 participants1 site · United StatesCompletes Jun 2027

Compare CT.gov Full analysis →

Recruiting

Ursodeoxycholic Acid (UDCA) as a Neuroprotective Adjuvant Treatment to Rhegmatogenous Retinal Detachment Surgery

Phase 3Retinal Detachment

UrsolvanPlacebo

Hopital Foch120 participants2 sites · FranceCompletes May 2027

Compare CT.gov Full analysis →

Recruiting

IRIS Registry: Intelligent Research in Sight Registry

N/AEye Diseases

Ophthalmology

American Academy of Ophthalmology20,000,000 participants1 site · United StatesCompletes Jan 2100

Compare CT.gov Full analysis →

Recruiting

Impact of Home Intraocular Pressure Telemonitoring on Intraocular Pressure Control and Glaucoma Progression

N/AGlaucomaIntraocular PressurePrimary Open Angle Glaucoma

Home IOP telemonitoring with smart phone-based interventionStandard care and smart phone-based intervention

The University of Hong Kong142 participants1 site · Hong KongCompletes Jun 2028

Compare CT.gov Full analysis →

Recruiting

Patient Preferences on Same-day Bilateral Intravitreal Dexamethasone Injections

N/AInformed ConsentPreference, Patient

Ozurdex (dexamethasone)

Copenhagen University Hospital, Rigshospitalet200 participants1 site · DenmarkCompletes Dec 2025

Compare CT.gov Full analysis →

1–15 of 157